Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells

Abstract Stromal fibroblasts, which occupy a major portion of the tumor microenvironment, play an important role in cancer metastasis. Thus, targeting of these fibroblasts activated by cancer cells (carcinoma‐associated fibroblasts; CAFs) might aid in the improved treatment of cancer metastasis. NIH...

Full description

Bibliographic Details
Main Authors: Kruthi Suvarna, Kaori Honda, Yasumitsu Kondoh, Hiroyuki Osada, Nobumoto Watanabe
Format: Article
Language:English
Published: Wiley 2018-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1339
_version_ 1797390055511162880
author Kruthi Suvarna
Kaori Honda
Yasumitsu Kondoh
Hiroyuki Osada
Nobumoto Watanabe
author_facet Kruthi Suvarna
Kaori Honda
Yasumitsu Kondoh
Hiroyuki Osada
Nobumoto Watanabe
author_sort Kruthi Suvarna
collection DOAJ
description Abstract Stromal fibroblasts, which occupy a major portion of the tumor microenvironment, play an important role in cancer metastasis. Thus, targeting of these fibroblasts activated by cancer cells (carcinoma‐associated fibroblasts; CAFs) might aid in the improved treatment of cancer metastasis. NIH3T3 fibroblasts cocultured with MCF7 cells displayed enhanced migration compared to NIH3T3 fibroblasts cultured alone. We used this system to identify the small‐molecule inhibitors responsible for their enhanced migration, a characteristic of CAFs. We selected β‐arrestin1, which showed high expression in cocultured cells, as a molecular target for such inhibitors. Cofilin, a protein downstream of β‐arrestin1, is activated/dephosphorylated in this condition. The small‐molecule ligands of β‐arrestin1 obtained by chemical array were then examined using a wound healing coculture assay. RKN5755 was identified as a selective inhibitor of activated fibroblasts. RKN5755 inhibited the enhanced migration of fibroblasts cocultured with cancer cells by binding to β‐arrestin1 and interfering with β‐arrestin1‐mediated cofilin signaling pathways. Therefore, these results demonstrate the role of β‐arrestin1 in the activation of fibroblasts and inhibiting this protein by small molecule inhibitor might be a potential therapeutic target for the stromal fibroblast activation (cancer–stroma interaction).
first_indexed 2024-03-08T23:06:05Z
format Article
id doaj.art-12dd83c85c3342e092b90f55e43a8350
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-08T23:06:05Z
publishDate 2018-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-12dd83c85c3342e092b90f55e43a83502023-12-15T12:32:12ZengWileyCancer Medicine2045-76342018-03-017388389310.1002/cam4.1339Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cellsKruthi Suvarna0Kaori Honda1Yasumitsu Kondoh2Hiroyuki Osada3Nobumoto Watanabe4Bio‐Active Compounds Discovery Research Unit RIKEN Center for Sustainable Resource Science Saitama JapanBio‐Active Compounds Discovery Research Unit RIKEN Center for Sustainable Resource Science Saitama JapanChemical Biology Research Group RIKEN Center for Sustainable Resource Science Saitama JapanChemical Biology Research Group RIKEN Center for Sustainable Resource Science Saitama JapanBio‐Active Compounds Discovery Research Unit RIKEN Center for Sustainable Resource Science Saitama JapanAbstract Stromal fibroblasts, which occupy a major portion of the tumor microenvironment, play an important role in cancer metastasis. Thus, targeting of these fibroblasts activated by cancer cells (carcinoma‐associated fibroblasts; CAFs) might aid in the improved treatment of cancer metastasis. NIH3T3 fibroblasts cocultured with MCF7 cells displayed enhanced migration compared to NIH3T3 fibroblasts cultured alone. We used this system to identify the small‐molecule inhibitors responsible for their enhanced migration, a characteristic of CAFs. We selected β‐arrestin1, which showed high expression in cocultured cells, as a molecular target for such inhibitors. Cofilin, a protein downstream of β‐arrestin1, is activated/dephosphorylated in this condition. The small‐molecule ligands of β‐arrestin1 obtained by chemical array were then examined using a wound healing coculture assay. RKN5755 was identified as a selective inhibitor of activated fibroblasts. RKN5755 inhibited the enhanced migration of fibroblasts cocultured with cancer cells by binding to β‐arrestin1 and interfering with β‐arrestin1‐mediated cofilin signaling pathways. Therefore, these results demonstrate the role of β‐arrestin1 in the activation of fibroblasts and inhibiting this protein by small molecule inhibitor might be a potential therapeutic target for the stromal fibroblast activation (cancer–stroma interaction).https://doi.org/10.1002/cam4.1339Fibroblastsligandssignal transductiontumor microenvironmentwound healing
spellingShingle Kruthi Suvarna
Kaori Honda
Yasumitsu Kondoh
Hiroyuki Osada
Nobumoto Watanabe
Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
Cancer Medicine
Fibroblasts
ligands
signal transduction
tumor microenvironment
wound healing
title Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
title_full Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
title_fullStr Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
title_full_unstemmed Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
title_short Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
title_sort identification of a small molecule ligand of β arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
topic Fibroblasts
ligands
signal transduction
tumor microenvironment
wound healing
url https://doi.org/10.1002/cam4.1339
work_keys_str_mv AT kruthisuvarna identificationofasmallmoleculeligandofbarrestin1asaninhibitorofstromalfibroblastcellmigrationacceleratedbycancercells
AT kaorihonda identificationofasmallmoleculeligandofbarrestin1asaninhibitorofstromalfibroblastcellmigrationacceleratedbycancercells
AT yasumitsukondoh identificationofasmallmoleculeligandofbarrestin1asaninhibitorofstromalfibroblastcellmigrationacceleratedbycancercells
AT hiroyukiosada identificationofasmallmoleculeligandofbarrestin1asaninhibitorofstromalfibroblastcellmigrationacceleratedbycancercells
AT nobumotowatanabe identificationofasmallmoleculeligandofbarrestin1asaninhibitorofstromalfibroblastcellmigrationacceleratedbycancercells